Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice
Main Authors: | Chen, Youfang, Du, Jianfeng, Zhao, Yu Tina, Zhang, Ling, Lv, Guorong, Zhuang, Shougang, Qin, Gangjian, Zhao, Ting C |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527099/ |
Similar Items
-
Inhibition of Oct 3/4 mitigates the cardiac progenitor-derived myocardial repair in infarcted myocardium
by: Zhao, Yu Tina, et al.
Published: (2015) -
Irisin Ameliorates Hypoxia/Reoxygenation-Induced Injury through Modulation of Histone Deacetylase 4
by: Zhao, Yu Tina, et al.
Published: (2016) -
Myocyte-specific overexpressing HDAC4 promotes myocardial ischemia/reperfusion injury
by: Ling Zhang, et al.
Published: (2018-07-01) -
Treatment of chronic kidney diseases with histone deacetylase inhibitors
by: Liu, Na, et al.
Published: (2015) -
Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast
by: Seo, Jinwon, et al.
Published: (2014)